Medpace Voice

In a process-oriented industry that breathes deeply from a standard set of regulations, it is easy to see the importance of each storage unit in…

To serve our Sponsors in their COVID-19 programs, Medpace has expedited COVID-19 assay validations to meet clinical trial testing standards.

As part of our efforts to expand laboratory services and capabilities, Medpace’s central lab in Belgium recently completed extensive expansions including a new modern laboratory…

Dr. El Mustapha Bahassi, Associate Director of Clinical Laboratories at Medpace, highlights the biomarker landscape in immuno-oncology clinical research.

Experts from Medpace’s central laboratory evaluated the effect of hemolysis, icterus and lipemia on chemistry assays and assessed the association between the amount of interfering…

Medpace offers global flow cytometry capabilities, with flow cytometry departments located at our US, Belgium and Singapore central laboratories.

With an already robust menu of validated assays, the increase in new biomarker assay validations speaks to the seamless service we provide to our Sponsors.

As part of our mission to deliver superb customer service and site support, we have recently expanded our kit building capabilities in the US and…

In this post, we highlight some of the key investments we have made in each of our biorepositories around the world and what that means…

With the advancement of precision medicine, molecular and genetic testing is becoming a critical component for patient selection and individual assessment of the risks and…